The global demand for Left Ventricular Assist Device Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Left ventricular assist device is a pump that helps left ventricle pump blood to the rest of the body, it is used by the patient who has reached end-stage of heart failure. The device helps weakened heart to restore normal blood flow. The LVAD is implanted surgically into a body, one end of the LVAD pump is attached to the LVAD pump and another end to the aorta. The blood flows from ventricular to LVAD, the LVAD pumps blood out into aorta then flows to rest of the body.
Heart failure is a major cause of death with prevalence estimated at 6.5 million adults, the prevalence will rise with the ageing of the population. This is anticipated to drive the growth of the market during the forecast period. Increasing life expectancy, healthcare spending, significant advancements in healthcare management as well as medical technology with arrivals of newer generation devices have improved patient outcomes, leading to the increasing use of LVAD. Left ventricular assist device is emerging as a durable and safe therapy for end-stage into the heart failure paradigm. However, the burden of adverse events remained the major restraining factor for the market in the current state of ventricular assist device therapy. Ongoing investigation and implication of future improvement in the device may eradicate this drawback.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Left Ventricular Assist Device.
The entire Left Ventricular Assist Device market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- BTT Therapy
- Destination Therapy (DT)
This section covers regional segmentation which accentuates on current and future demand for Left Ventricular Assist Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Left Ventricular Assist Device Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Left Ventricular Assist Device market include AbioMed, Berlin Heart, Abbott (Thoratec), ReliantHeart, and Medtronic (HeartWare). This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.